ICL Group (NYSE: ICL) CFO details significant stock option holdings

Rhea-AI Filing Summary

ICL Group Ltd. Chief Financial Officer Lahav Aviram reported his initial holdings of stock options linked to the company’s ordinary shares. He holds stock options over 784,918 underlying ordinary shares at an exercise price of $9.39 per share, expiring on February 8, 2027. He also holds stock options over 1,189,861 underlying ordinary shares at an exercise price of $5.87 per share, expiring on April 4, 2029. According to the notes, one option grant is fully vested and exercisable, while the other vests in three equal annual installments from the April 4, 2024 grant date, and the options are held by a trustee in his name.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Lahav Aviram

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Stock Options (Right to Buy)	--	--	--
holding	Stock Options (Right to Buy)	--	--	--

Holdings After Transaction: Stock Options (Right to Buy) — 784,918 shares (Direct)

Footnotes (1)

1. The stock options are fully vested and exercisable The stock options vest in three equal annual installments from the April 4, 2024 grant date. Represents an exercise price of NIS 29.57, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026. The options are held by a Trustee in the name of the Reporting Person. Represents an exercise price of NIS 18.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

Key Figures

Underlying shares (first grant): 784,918 shares Exercise price (first grant): $9.39 per share Underlying shares (second grant): 1,189,861 shares +1 more

4 metrics

Underlying shares (first grant) 784,918 shares Stock options over ordinary shares at $9.39 exercise price

Exercise price (first grant) $9.39 per share Stock options expiring February 8, 2027

Underlying shares (second grant) 1,189,861 shares Stock options over ordinary shares at $5.87 exercise price

Exercise price (second grant) $5.87 per share Stock options expiring April 4, 2029

Key Terms

Stock Options (Right to Buy), Ordinary Shares, exercise price, vest in three equal annual installments, +1 more

5 terms

Stock Options (Right to Buy) financial

"security_title: "Stock Options (Right to Buy)""

Ordinary Shares financial

"underlying_security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

exercise price financial

"Represents an exercise price of NIS 29.57, converted to U.S. dollars"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest in three equal annual installments financial

"The stock options vest in three equal annual installments from the April 4, 2024 grant date."

Trustee financial

"The options are held by a Trustee in the name of the Reporting Person."

A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lahav Aviram

(Last) (First) (Middle)

C/O ICL GROUP LTD.

MILLENNIUM TOWER, 23 ARENHA ST.

(Street)

TEL AVIV 6120201

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ICL Group Ltd. [ ICL ]

3a. Foreign Trading Symbol
[ICL]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	(1)	02/08/2027	Ordinary Shares	784,918	$9.39(3)	D(4)
Stock Options (Right to Buy)	(2)	04/04/2029	Ordinary Shares	1,189,861	$5.87(5)	D(4)

Explanation of Responses:

1. The stock options are fully vested and exercisable

2. The stock options vest in three equal annual installments from the April 4, 2024 grant date.

3. Represents an exercise price of NIS 29.57, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

4. The options are held by a Trustee in the name of the Reporting Person.

5. Represents an exercise price of NIS 18.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

	/s/ Lahav Aviram	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the ICL (ICL) Form 3 filing by CFO Lahav Aviram show?

The Form 3 shows CFO Lahav Aviram’s initial stock option holdings in ICL Group Ltd. It lists two option grants over 784,918 and 1,189,861 underlying ordinary shares, with specified exercise prices, vesting schedules, and expiration dates, establishing his starting derivative position.

How many ICL (ICL) shares underlie Lahav Aviram’s reported stock options?

Lahav Aviram’s options cover 784,918 underlying ordinary shares in one grant and 1,189,861 underlying ordinary shares in another. These figures indicate the number of ICL ordinary shares he can acquire if he chooses to exercise the respective option awards.

What are the exercise prices of the ICL (ICL) stock options held by the CFO?

The filing reports exercise prices of $9.39 per share for options over 784,918 underlying ordinary shares and $5.87 per share for options over 1,189,861 underlying ordinary shares. These are the prices he would pay per share if he exercises each respective option grant.

When do Lahav Aviram’s ICL (ICL) stock options expire?

One stock option grant over 784,918 underlying ordinary shares expires on February 8, 2027. The other grant over 1,189,861 underlying ordinary shares expires on April 4, 2029. These dates define the last days he can exercise each option award, assuming they are vested.

How do the ICL (ICL) CFO’s stock options vest according to the Form 3 footnotes?

One option grant is described as fully vested and exercisable, meaning all related shares are currently available upon exercise. The other grant vests in three equal annual installments beginning from the April 4, 2024 grant date, gradually increasing the number of exercisable shares over time.

Who legally holds the ICL (ICL) CFO’s stock options reported on Form 3?

The footnotes state the options are held by a trustee in the name of the reporting person. This means a trustee entity formally holds the options on his behalf, while the filing still attributes the derivative holdings to CFO Lahav Aviram as the reporting person.